In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia
Although progress in children, in adults, ALL still carries a dismal outcome. Here, we explored the in vitro and in vivo activity of PF-00477736 (Pfizer), a potent, selective ATP-competitive small-molecule inhibitor of checkpoint kinase 1 (Chk1) and with lower efficacy of checkpoint kinase 2 (Chk2).The effectiveness of PF-00477736 as single agent in B-/T-ALL was evaluated in vitro and in vivo studies as a single agent. The efficacy of the compound in terms of cytotoxicity, induction of apoptosis, and changes in gene and protein expression was assessed using different B-/T-ALL cell lines. Finally, the action of PF-00477736 was assessed in vivo using leukemic mouse generated by a single administration of the tumorigenic agent N-ethyl-N-nitrosourea.Chk1 and Chk2 are overexpressed concomitant with the presence of genetic damage as suggested by the nuclear labeling for γ-H2A.X (Ser139) in 68 % of ALL patients. In human B- and T-ALL cell lines, inhibition of Chk1/2 as a single treatment strategy efficiently triggered the Chk1-Cdc25-Cdc2 pathway resulting in a dose- and time-dependent cytotoxicity, induction of apoptosis, and increased DNA damage. Moreover, treatment with PF-00477736 showed efficacy ex vivo in primary leukemic blasts separated from 14 adult ALL patients and in vivo in mice transplanted with T-ALL, arguing in favor of its future clinical evaluation in leukemia.In vitro, ex vivo, and in vivo results support the inhibition of Chk1 as a new therapeutic strategy in acute lymphoblastic leukemia, and they provide a strong rationale for its future clinical investigation.
Cancer Research, acute lymphoblastic leukemia; checkpoint kinase; dna damage; drug-sensitivity; new targets; animals; apoptosis; benzodiazepinones; blotting, western; cell cycle; cell line, tumor; cell survival; dose-response relationship, drug; gene expression profiling; gene expression regulation, leukemic; humans; leukemia, experimental; mice, inbred c57bl; microscopy, fluorescence; neoplastic stem cells; precursor b-cell lymphoblastic leukemia-lymphoma; precursor t-cell lymphoblastic leukemia-lymphoma; protein kinase inhibitors; protein kinases; pyrazoles; survival analysis; hematology; oncology; cancer research; molecular biology, Cell Survival, Blotting, Western, 610, Apoptosis, Acute lymphoblastic leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Settore MED/05 - PATOLOGIA CLINICA, Cell Line, Tumor, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Animals, Humans, New targets, Molecular Biology, Protein Kinase Inhibitors, Benzodiazepinones, Leukemia, Experimental, Dose-Response Relationship, Drug, Gene Expression Regulation, Leukemic, Research, Gene Expression Profiling, Drug-sensitivity, Cell Cycle, Hematology, Acute lymphoblastic leukemia; Checkpoint kinase; DNA damage; Drug-sensitivity; New targets; Animals; Apoptosis; Benzodiazepinones; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Leukemia, Experimental; Mice, Inbred C57BL; Microscopy, Fluorescence; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Survival Analysis; Hematology; Oncology; Cancer Research; Molecular Biology, Mice, Inbred C57BL, Oncology, Microscopy, Fluorescence, Checkpoint Kinase 1, Neoplastic Stem Cells, DNA damage, Checkpoint kinase, Protein Kinases
Cancer Research, acute lymphoblastic leukemia; checkpoint kinase; dna damage; drug-sensitivity; new targets; animals; apoptosis; benzodiazepinones; blotting, western; cell cycle; cell line, tumor; cell survival; dose-response relationship, drug; gene expression profiling; gene expression regulation, leukemic; humans; leukemia, experimental; mice, inbred c57bl; microscopy, fluorescence; neoplastic stem cells; precursor b-cell lymphoblastic leukemia-lymphoma; precursor t-cell lymphoblastic leukemia-lymphoma; protein kinase inhibitors; protein kinases; pyrazoles; survival analysis; hematology; oncology; cancer research; molecular biology, Cell Survival, Blotting, Western, 610, Apoptosis, Acute lymphoblastic leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Settore MED/05 - PATOLOGIA CLINICA, Cell Line, Tumor, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Animals, Humans, New targets, Molecular Biology, Protein Kinase Inhibitors, Benzodiazepinones, Leukemia, Experimental, Dose-Response Relationship, Drug, Gene Expression Regulation, Leukemic, Research, Gene Expression Profiling, Drug-sensitivity, Cell Cycle, Hematology, Acute lymphoblastic leukemia; Checkpoint kinase; DNA damage; Drug-sensitivity; New targets; Animals; Apoptosis; Benzodiazepinones; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Leukemia, Experimental; Mice, Inbred C57BL; Microscopy, Fluorescence; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Survival Analysis; Hematology; Oncology; Cancer Research; Molecular Biology, Mice, Inbred C57BL, Oncology, Microscopy, Fluorescence, Checkpoint Kinase 1, Neoplastic Stem Cells, DNA damage, Checkpoint kinase, Protein Kinases
20 Research products, page 1 of 2
- 2017IsRelatedTo
- 2009IsAmongTopNSimilarDocuments
- 2014IsAmongTopNSimilarDocuments
- 2017IsRelatedTo
- 2014IsAmongTopNSimilarDocuments
- 2012IsAmongTopNSimilarDocuments
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).28 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
